7/18/2005

Biotech, led by Genentech, was the best performing industry in the U.S. stock market in the second quarter, with shares in the index increasing 14.5% during that time. In Australia, analysts are saying the biotech sector is poised to move upward, but still faces the problem of turning its scientific knowledge into commercial products.

Related Summaries